Highline Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-774,910
| Closed | -$24.3M | – | 40 |
|
|
2018
Q2 | $24.3M | Sell |
774,910
-255,000
| -25% | -$7.98M | 0.81% | 29 |
|
|
2018
Q1 | $22.5M | Sell |
1,029,910
-444,700
| -30% | -$9.69M | 0.77% | 27 |
|
|
2017
Q4 | $29.8M | Sell |
1,474,610
-39,400
| -3% | -$796K | 0.99% | 27 |
|
|
2017
Q3 | $30.1M | Sell |
1,514,010
-221,800
| -13% | -$4.4M | 0.85% | 26 |
|
|
2017
Q2 | $30M | Sell |
1,735,810
-59,900
| -3% | -$1.04M | 0.95% | 26 |
|
|
2017
Q1 | $14.5M | Sell |
1,795,710
-22,369
| -1% | -$181K | 0.42% | 30 |
|
|
2016
Q4 | $14.3M | Hold |
1,818,079
| – | – | 0.41% | 28 |
|
|
2016
Q3 | $15.5M | Buy |
1,818,079
+62,200
| +4% | +$531K | 0.53% | 27 |
|
|
2016
Q2 | $20.5M | Buy |
1,755,879
+222,200
| +14% | +$2.59M | 0.78% | 24 |
|
|
2016
Q1 | $22.2M | Buy |
1,533,679
+109,639
| +8% | +$1.59M | 0.94% | 25 |
|
|
2015
Q4 | $30.3M | Buy |
+1,424,040
| New | +$30.3M | 1.43% | 23 |
|